Journal profile · Endocrinology & Metabolism
Clinical Endocrinology
ISSN 0300-0664 · eISSN 1365-2265 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 1972
Clinical Endocrinology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.76; hybrid open access; APC about USD 4,250; median 90 days to acceptance (87 articles, last 24 months); community-reported acceptance: about 75%; 226 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Endocrinology is published by Wiley-Blackwell Publishing Ltd and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Growth Hormone and Insulin-like Growth Factors, Pituitary Gland Disorders and Treatments and Thyroid Disorders and Treatments, together about 34.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Clinical Endocrinology publishes papers and reviews which focus on the clinical aspects of endocrinology, including the clinical application of molecular endocrinology. It does not publish papers relating directly to diabetes care and clinical management. It features reviews, original papers, commentaries, correspondence and Clinical Questions. Clinical Endocrinology is essential reading not only for those engaged in endocrinological research but also for those involved primarily in clinical practice. • Negative/null results In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Henrik FalhammarPublisher website
Editorial board by country: 4 in mainland China (about 10%); most named United Kingdom 13, Australia 10, Mainland China 4, France 2, Italy 2 (39 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Growth Hormone and Insulin-like Growth FactorsMedicine12%
- Pituitary Gland Disorders and TreatmentsMedicine11.5%
- Thyroid Disorders and TreatmentsMedicine10.8%
- Adrenal Hormones and DisordersMedicine6.7%
- Thyroid Cancer Diagnosis and TreatmentMedicine6.6%
- Ovarian function and disordersMedicine5.3%
- Hormonal and reproductive studiesMedicine4.7%
- Adrenal and Paraganglionic TumorsMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.76LetPub ·
- Impact factor (publisher) 2025
- 2.8Publisher website ·
- Impact factor (publisher) 2019
- 3.38Publisher website ·
- CiteScore 2026-06
- 6.2LetPub ·
- CiteScore (publisher)
- 6.2Publisher website ·
- CiteScore (publisher) 2025
- 6.2Publisher website ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.26LetPub ·
- h-index
- 137LetPub ·
- h-index
- 213OpenAlex ·
- i10-index
- 8,434OpenAlex ·
- 2-year mean citedness
- 2.35OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 43.71%LetPub ·
Volume
- Articles per year
- 177LetPub ·
- Articles per year (publisher) 2025
- 199Publisher website ·
- Downloads per year (publisher)
- 2,020Publisher website ·
- Downloads per year (publisher) 2025
- 893,545Publisher website ·
Articles by year OpenAlex count · 12,624 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 126 | 71 | 35 |
| 2025 | 226 | 155 | 484 |
| 2024 | 180 | 120 | 732 |
| 2023 | 168 | 119 | 1,137 |
| 2022 | 211 | 99 | 2,224 |
| 2021 | 268 | 108 | 4,472 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 67 days – 126 days
- Acceptance to online
- median 10 days (87 articles)
- Submission to online
- median 106 days
- Sample
- 87 articles with submission and acceptance dates (388 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Acceptance rate (publisher)
- 14%Publisher website ·
- Acceptance rate (publisher) 2025
- 14%Publisher website ·
- Submission to first decision
- 6 daysPublisher website ·
- Submission to first decision 2025
- 6 daysPublisher website ·
- Submission to acceptance 2025
- 100 daysPublisher website ·
- Acceptance to publication 2025
- 11 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,250 / EUR 3,550 / GBP 2,830 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6, with length limits
- clinical questionsClinical Question articles are focused answers to specific clinical questions and answers to many of these rely heavily on clinical experience.Length not stated
- correspondencealso be considered under this heading. Correspondence should not exceed 1000 words, have no more than 5 references and only 1 figure / table.main text ≤ 1,000 words
- original articlesignificant contribution to knowledge. Original articles should be no more than 3,500 words (excluding abstract, references, figure or table legends),main text ≤ 3,500 words
- original articlesOriginal articles should contain reports of new research findings or conceptual analyses that make a significant contribution to knowledge.Length not stated
- rapid communicationsRapid communications may be published more quickly than original articles with an expected publication time of 3 months after acceptance.Length not stated
- review articlesReview articles are normally commissioned, but we welcome suggestions for review titles and authors.Length not stated
Policy excerpts from the journal's websiteAuthorship, Publication ethics, Peer review, Preprints
- Authorship Changes to authorship
Best Practice Guidelines on Research Integrity and Publishing Ethics
Source ↗Publisher website ·- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and AcceptanceThe acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editors-in-Chief determine that the paper meets the appropriate quality and relevance requirements. Wiley's policy on confide…
Source ↗Publisher website ·- Peer review
Peer review model: single-blind. Model summary
Except where otherwise stated, manuscripts are single-blind peer reviewed.
Source ↗Publisher website ·- Preprints Preprint Policy:
Preprint policy: considers preprints on non-commercial servers. Model summary
Wiley believes that journals publishing for communities with established pre-print servers should allow authors to submit manuscripts which have already been made available on a non-commercial preprint server. Allowing submission does not, of course, guarantee that an article will be sent out for review. It simply reflects our belief that journals should not rule out reviewing a paper simply becau…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1972
- ISSN
- 0300-0664
- Electronic ISSN
- 1365-2265
- Latest issue on the website
- Volume 105, Issue 4 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Clinical Endocrinology
What CAS zone is Clinical Endocrinology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Endocrinology is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Endocrinology?
The latest impact factor listed by LetPub is 2.76; CiteScore 6.2, h-index 213.
How long does peer review take at Clinical Endocrinology?
Based on the dates recorded on 87 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 67–126 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”; the journal's website gives an acceptance rate of 14% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical Endocrinology based?
Of the 39 board members whose country the journal's board page names, 4 (about 10%) are in mainland China; the countries named most often are United Kingdom (13), Australia (10) and Mainland China (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Endocrinology?
According to LetPub and DOAJ records, Clinical Endocrinology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Clinical Endocrinology open access, and what is the APC?
Clinical Endocrinology is a hybrid journal. For open-access publication: APC about USD 4,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .